GABRIEL LEUNG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GABRIEL LEUNG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GABRIEL LEUNG. GABRIEL LEUNG is Exec. VP, Pres., Oncology Bus. in OSI PHARMACEUTICALS INC ($OSIP) and Exec. VP,/Pres., Oncology Bus. in OSI PHARMACEUTICALS INC ($OSIP) and Director in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA) and Director in ALBANY MOLECULAR RESEARCH INC ($AMRI) and Director in Novocure Ltd ($NVCR).
Latest Insider Trading Transactions of GABRIEL LEUNG
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRI, NVCR, OSIP, GTA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 15 2021 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 31.45 | 6,000 | 188,700 | 6,345 | |
Apr 15 2021 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 200.00 | 2,500 | 500,000 | 72,045 | 74.5 K to 72 K (-3.35 %) |
Apr 15 2021 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 198.01 | 3,500 | 693,035 | 74,545 | 78 K to 74.5 K (-4.48 %) |
Apr 15 2021 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 31.45 | 6,000 | 188,700 | 78,045 | 72 K to 78 K (+8.33 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.48 | 7,392 | 55,292 | 0 | |
Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.48 | 2,173 | 16,254 | 0 | |
Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.48 | 10,000 | 74,800 | 2,173 | |
Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 100.00 | 7,392 | 739,200 | 72,045 | 79.4 K to 72 K (-9.31 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.48 | 7,392 | 55,292 | 79,437 | 72 K to 79.4 K (+10.26 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 100.00 | 2,173 | 217,300 | 72,045 | 74.2 K to 72 K (-2.93 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.48 | 2,173 | 16,254 | 74,218 | 72 K to 74.2 K (+3.02 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 95.00 | 10,000 | 950,000 | 72,045 | 82 K to 72 K (-12.19 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.48 | 10,000 | 74,800 | 82,045 | 72 K to 82 K (+13.88 %) |
Sep 11 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.48 | 10,000 | 74,800 | 12,173 | |
Sep 11 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 9,114 | 64,071 | 0 | |
Sep 11 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 90.00 | 10,000 | 900,000 | 72,045 | 82 K to 72 K (-12.19 %) |
Sep 11 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.48 | 10,000 | 74,800 | 82,045 | 72 K to 82 K (+13.88 %) |
Sep 11 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 86.06 | 100 | 8,606 | 72,045 | 72.1 K to 72 K (-0.14 %) |
Sep 11 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 85.39 | 9,014 | 769,687 | 72,145 | 81.2 K to 72.1 K (-11.11 %) |
Sep 11 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 9,114 | 64,071 | 81,159 | 72 K to 81.2 K (+12.65 %) |
Sep 04 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 100 | 703 | 9,114 | |
Sep 04 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 85.00 | 100 | 8,500 | 72,045 | 72.1 K to 72 K (-0.14 %) |
Sep 04 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 100 | 703 | 72,145 | 72 K to 72.1 K (+0.14 %) |
Aug 03 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 7,112 | 49,997 | 7,112 | |
Aug 03 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 75.00 | 7,112 | 533,400 | 72,045 | 79.2 K to 72 K (-8.98 %) |
Aug 03 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 7,112 | 49,997 | 79,157 | 72 K to 79.2 K (+9.87 %) |
Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 9,500 | 66,785 | 9,214 | |
Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 500 | 3,515 | 18,714 | |
Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 67.46 | 4,504 | 303,844 | 72,045 | 76.5 K to 72 K (-5.88 %) |
Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 66.75 | 4,573 | 305,257 | 76,549 | 81.1 K to 76.5 K (-5.64 %) |
Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 65.48 | 423 | 27,696 | 81,122 | 81.5 K to 81.1 K (-0.52 %) |
Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 9,500 | 66,785 | 81,545 | 72 K to 81.5 K (+13.19 %) |
Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 65.07 | 500 | 32,537 | 72,045 | 72.5 K to 72 K (-0.69 %) |
Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 500 | 3,515 | 72,545 | 72 K to 72.5 K (+0.69 %) |
Jun 12 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | A | 67.89 | 5,101 | 346,307 | 5,101 | |
Jun 12 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Grant | A | 0.00 | 2,541 | 0 | 72,045 | 69.5 K to 72 K (+3.66 %) |
Nov 26 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 20,000 | 140,600 | 19,214 | |
Nov 26 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 95.00 | 20,000 | 1,900,000 | 69,504 | 89.5 K to 69.5 K (-22.35 %) |
Nov 26 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 20,000 | 140,600 | 89,504 | 69.5 K to 89.5 K (+28.78 %) |
Nov 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 20,000 | 140,600 | 39,214 | |
Nov 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 90.00 | 20,000 | 1,800,000 | 69,504 | 89.5 K to 69.5 K (-22.35 %) |
Nov 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 20,000 | 140,600 | 89,504 | 69.5 K to 89.5 K (+28.78 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 10,000 | 70,300 | 59,214 | |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 5,257 | 36,957 | 69,214 | |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 4,743 | 16,316 | 0 | |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 85.00 | 10,000 | 850,000 | 69,504 | 79.5 K to 69.5 K (-12.58 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 10,000 | 70,300 | 79,504 | 69.5 K to 79.5 K (+14.39 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 84.00 | 354 | 29,737 | 69,504 | 69.9 K to 69.5 K (-0.51 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 83.51 | 3,203 | 267,486 | 69,858 | 73.1 K to 69.9 K (-4.38 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 82.52 | 1,700 | 140,282 | 73,061 | 74.8 K to 73.1 K (-2.27 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 5,257 | 36,957 | 74,761 | 69.5 K to 74.8 K (+7.56 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 84.02 | 443 | 37,220 | 69,504 | 69.9 K to 69.5 K (-0.63 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 83.50 | 2,800 | 233,803 | 69,947 | 72.7 K to 69.9 K (-3.85 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 82.55 | 1,500 | 123,825 | 72,747 | 74.2 K to 72.7 K (-2.02 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 4,743 | 16,316 | 74,247 | 69.5 K to 74.2 K (+6.82 %) |
Nov 13 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 4,743 | |
Nov 13 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 79.57 | 5,000 | 397,850 | 69,504 | 74.5 K to 69.5 K (-6.71 %) |
Nov 13 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 74,504 | 69.5 K to 74.5 K (+7.19 %) |
Oct 15 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 9,743 | |
Oct 15 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 72.28 | 5,000 | 361,400 | 69,504 | 74.5 K to 69.5 K (-6.71 %) |
Oct 15 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 74,504 | 69.5 K to 74.5 K (+7.19 %) |
Sep 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 14,743 | |
Sep 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 76.63 | 5,000 | 383,150 | 69,504 | 74.5 K to 69.5 K (-6.71 %) |
Sep 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 74,504 | 69.5 K to 74.5 K (+7.19 %) |
Jul 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 24,743 | |
Jul 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 64.83 | 5,000 | 324,155 | 69,504 | 74.5 K to 69.5 K (-6.71 %) |
Jul 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 74,504 | 69.5 K to 74.5 K (+7.19 %) |
Jun 21 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 25,000 | 86,000 | 29,743 | |
Jun 21 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 60.02 | 25,000 | 1,500,500 | 69,504 | 94.5 K to 69.5 K (-26.45 %) |
Jun 21 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 25,000 | 86,000 | 94,504 | 69.5 K to 94.5 K (+35.97 %) |
Jun 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 54,743 | |
Jun 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 55.60 | 100 | 5,560 | 69,504 | 69.6 K to 69.5 K (-0.14 %) |
Jun 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 55.04 | 4,900 | 269,706 | 69,604 | 74.5 K to 69.6 K (-6.58 %) |
Jun 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 74,504 | 69.5 K to 74.5 K (+7.19 %) |
May 24 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | A | 51.36 | 6,340 | 325,622 | 6,340 | |
May 24 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Grant | A | 0.00 | 3,359 | 0 | 69,504 | 66.1 K to 69.5 K (+5.08 %) |
May 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 0.00 | 6,145 | 0 | 0 | |
May 22 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 48.87 | 6,145 | 300,306 | 66,145 | 60 K to 66.1 K (+10.24 %) |
May 14 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 59,743 | |
May 14 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 49.79 | 5,000 | 248,950 | 60,000 | 65 K to 60 K (-7.69 %) |
May 14 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 65,000 | 60 K to 65 K (+8.33 %) |
Apr 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 64,743 | |
Apr 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 45.95 | 5,000 | 229,750 | 60,000 | 65 K to 60 K (-7.69 %) |
Apr 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 65,000 | 60 K to 65 K (+8.33 %) |
Mar 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 69,743 | |
Mar 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 48.31 | 5,000 | 241,550 | 60,000 | 65 K to 60 K (-7.69 %) |
Mar 12 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 65,000 | 60 K to 65 K (+8.33 %) |
Jan 28 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 20,000 | 68,800 | 104,743 | |
Jan 28 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 50.00 | 20,000 | 1,000,000 | 60,000 | 80 K to 60 K (-25.00 %) |
Jan 28 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 20,000 | 68,800 | 80,000 | 60 K to 80 K (+33.33 %) |
Jan 18 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 20,000 | 68,800 | 124,743 | |
Jan 18 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 45.00 | 20,000 | 900,060 | 60,000 | 80 K to 60 K (-25.00 %) |
Jan 18 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 20,000 | 68,800 | 80,000 | 60 K to 80 K (+33.33 %) |
Jan 14 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 144,743 | |
Jan 14 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 39.91 | 5,000 | 199,550 | 60,000 | 65 K to 60 K (-7.69 %) |
Jan 14 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 65,000 | 60 K to 65 K (+8.33 %) |
Jan 11 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 20,000 | 68,800 | 149,743 | |
Jan 11 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 40.01 | 6,726 | 269,107 | 60,000 | 66.7 K to 60 K (-10.08 %) |
Jan 11 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 40.00 | 13,274 | 530,960 | 66,726 | 80 K to 66.7 K (-16.59 %) |
Jan 11 2019 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 20,000 | 68,800 | 80,000 | 60 K to 80 K (+33.33 %) |
Dec 12 2018 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 5,000 | 17,200 | 169,743 | |
Dec 12 2018 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 33.49 | 5,000 | 167,450 | 60,000 | 65 K to 60 K (-7.69 %) |
Dec 12 2018 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 5,000 | 17,200 | 65,000 | 60 K to 65 K (+8.33 %) |
Jun 04 2018 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | A | 0.00 | 6,145 | 0 | 6,145 | |
Jun 04 2018 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | A | 31.45 | 12,345 | 388,250 | 12,345 | |
May 23 2018 | GTA | PERNIX THERAPEUTIC ... | LEUNG GABRIEL | Director | Option Exercise | A | 2.63 | 25,000 | 65,750 | 25,000 | |
May 17 2018 | NVCR | Novocure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 100,000 | 344,000 | 174,743 | |
May 17 2018 | NVCR | Novocure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 3.44 | 40,000 | 137,600 | 274,743 | |
May 17 2018 | NVCR | Novocure Ltd | LEUNG GABRIEL | Director | Sell | S | 28.77 | 40,000 | 1,150,800 | 60,000 | 100 K to 60 K (-40.00 %) |
May 17 2018 | NVCR | Novocure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 100,000 | 344,000 | 100,000 | 0 to 100 K |
May 17 2018 | NVCR | Novocure Ltd | LEUNG GABRIEL | Director | Sell | S | 28.88 | 40,000 | 1,155,200 | 0 | 40 K to 0 (-100.00 %) |
May 17 2018 | NVCR | Novocure Ltd | LEUNG GABRIEL | Director | Buy | M | 3.44 | 40,000 | 137,600 | 40,000 | 0 to 40 K |
Nov 17 2017 | GTA | PERNIX THERAPEUTIC ... | LEUNG GABRIEL | Director | Option Exercise | A | 2.97 | 50,000 | 148,500 | 50,000 | |
Nov 22 2016 | GTA | PERNIX THERAPEUTIC ... | LEUNG GABRIEL | Director | Option Exercise | A | 3.50 | 4,000 | 14,000 | 4,000 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | LEUNG GABRIEL | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | LEUNG GABRIEL | Director | Grant | A | 17.05 | 2,639 | 44,995 | 31,316 | 28.7 K to 31.3 K (+9.20 %) |
Jun 17 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., On ... | Option Exercise | A | 38.01 | 36,430 | 1,384,704 | 36,430 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 2,479 | 59,124 | 60,761 | |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 50.00 | 2,479 | 123,950 | 10,429 | 12.9 K to 10.4 K (-19.21 %) |
Apr 19 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 2,479 | 59,124 | 12,908 | 10.4 K to 12.9 K (+23.77 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 2,191 | 52,255 | 63,240 | |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.70 | 27 | 1,477 | 10,429 | 10.5 K to 10.4 K (-0.26 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.50 | 15 | 818 | 10,456 | 10.5 K to 10.5 K (-0.14 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.31 | 16 | 869 | 10,471 | 10.5 K to 10.5 K (-0.15 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.30 | 31 | 1,683 | 10,487 | 10.5 K to 10.5 K (-0.29 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.12 | 124 | 6,711 | 10,518 | 10.6 K to 10.5 K (-1.17 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.11 | 16 | 866 | 10,642 | 10.7 K to 10.6 K (-0.15 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.10 | 591 | 31,973 | 10,658 | 11.2 K to 10.7 K (-5.25 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.05 | 103 | 5,567 | 11,249 | 11.4 K to 11.2 K (-0.91 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.02 | 16 | 864 | 11,352 | 11.4 K to 11.4 K (-0.14 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.01 | 46 | 2,484 | 11,368 | 11.4 K to 11.4 K (-0.40 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 54.00 | 202 | 10,908 | 11,414 | 11.6 K to 11.4 K (-1.74 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 53.94 | 114 | 6,149 | 11,616 | 11.7 K to 11.6 K (-0.97 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 53.91 | 16 | 863 | 11,730 | 11.7 K to 11.7 K (-0.14 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 53.86 | 31 | 1,670 | 11,746 | 11.8 K to 11.7 K (-0.26 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 53.84 | 310 | 16,690 | 11,777 | 12.1 K to 11.8 K (-2.56 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 53.83 | 338 | 18,195 | 12,087 | 12.4 K to 12.1 K (-2.72 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 53.82 | 62 | 3,337 | 12,425 | 12.5 K to 12.4 K (-0.50 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 53.81 | 16 | 861 | 12,487 | 12.5 K to 12.5 K (-0.13 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 53.80 | 31 | 1,668 | 12,503 | 12.5 K to 12.5 K (-0.25 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 53.76 | 86 | 4,623 | 12,534 | 12.6 K to 12.5 K (-0.68 %) |
Mar 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 2,191 | 52,255 | 12,620 | 10.4 K to 12.6 K (+21.01 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 5,610 | 133,799 | 65,431 | |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 65.16 | 1,042 | 67,897 | 10,429 | 11.5 K to 10.4 K (-9.08 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 65.15 | 300 | 19,545 | 11,471 | 11.8 K to 11.5 K (-2.55 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 65.10 | 802 | 52,210 | 11,771 | 12.6 K to 11.8 K (-6.38 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 65.00 | 3,466 | 225,290 | 12,573 | 16 K to 12.6 K (-21.61 %) |
Feb 03 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 5,610 | 133,799 | 16,039 | 10.4 K to 16 K (+53.79 %) |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 30.74 | 4,328 | 133,043 | 28,141 | |
Jan 05 2005 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Option Exercise | M | 23.85 | 1,459 | 34,797 | 71,041 |